Esomeprazole and omeprazole could possibly boost the serum concentrations of benzodiazepines (by using CYP2C19 inhibition) bringing about enhanced adverse effects including drowsiness, although the clinical relevance is low in most patients – monitor the affected individual for adverse effects (e.If affected person simply cannot resume their comm